Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

PAX7 Antikörper (Internal Region)

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch PAX7 in WB und ELISA. Er zeigt eine Reaktivität gegenüber Maus.
Produktnummer ABIN7565803

Kurzübersicht für PAX7 Antikörper (Internal Region) (ABIN7565803)

Target

Alle PAX7 Antikörper anzeigen
PAX7 (Paired Box 7 (PAX7))

Reaktivität

  • 105
  • 65
  • 51
  • 18
  • 16
  • 8
  • 8
  • 7
  • 7
  • 4
  • 3
  • 3
  • 1
  • 1
Maus

Wirt

  • 70
  • 38
  • 1
  • 1
Kaninchen

Klonalität

  • 62
  • 48
Polyklonal

Konjugat

  • 52
  • 7
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser PAX7 Antikörper ist unkonjugiert

Applikation

  • 80
  • 32
  • 31
  • 30
  • 18
  • 15
  • 13
  • 13
  • 13
  • 9
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA
  • Bindungsspezifität

    • 23
    • 16
    • 9
    • 9
    • 7
    • 7
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Internal Region

    Verwendungszweck

    Pax7 Antibody

    Kreuzreaktivität (Details)

    A BLAST analysis was used to suggest cross reactivity with Pax7 protein from mouse (100 % homology) and human (66.

    Produktmerkmale

    Synonyms: rabbit anti-Pax7 antibody, Paired box protein Pax-7, Pax 7, Pax-7

    Aufreinigung

    Anti-Pax-7 was affinity purified from monospecific antiserum by immunoaffinity chromatography.

    Sterilität

    Sterile filtered

    Immunogen

    Immunogen: Pax7 affinity purified antibody was prepared from whole rabbit serum produced by repeated immunizations with a synthetic peptide corresponding to an internal region of Pax7 protein.

    Immunogen Type: Conjugated Peptide

  • Applikationshinweise

    Application Note: Anti-Pax7 antibody has been tested in ELISA and Western Blot.  Specific conditions for reactivity should be optimized by the end user.  Expect a band approximately 54.9 kDa in size corresponding to Pax7 by western blotting in the appropriate cell lysate or extract. Western Blot Dilution: 1.0 μg/mL ELISA Dilution: 1:10,000-1:40:000

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    1.0 mg/mL

    Buffer

    Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2

    Stabilizer: None

    Preservative: 0.01 % (w/v) Sodium Azide

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Store vial at -20° C or below prior to opening. This vial contains a relatively low volume of reagent (25 μL). To minimize loss of volume dilute 1:10 by adding 225 μL of the buffer stated above directly to the vial. Recap, mix thoroughly and briefly centrifuge to collect the volume at the bottom of the vial. Use this intermediate dilution when calculating final dilutions as recommended below. Store the vial at -20°C or below after dilution. Avoid cycles of freezing and thawing.

    Haltbarkeit

    12 months
  • Target

    PAX7 (Paired Box 7 (PAX7))

    Andere Bezeichnung

    Pax7

    Hintergrund

    Background: The Anti-Pax7 antibody was designed, produced, and validated as part of the Joy Cappel Young Investigator Award (JCYIA). Paired box protein Pax-7 transcription factor plays a role in myogenesis through regulation of muscle precursor cells proliferation. These genes play critical roles during fetal development and cancer growth. It is expressed specifically during the development of the nervous and muscular system. Anti-Pax7 antibody is ideal for researchers interested in developmental biology, stem cell research, cell growth and cancer research.

    Gen-ID

    18509

    NCBI Accession

    NP_035169

    UniProt

    P47239
Sie sind hier:
Chat with us!